Company: IMNN
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001641172-25-013088
Chunk: 10

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 10
---
 of 10 consecutive business days at any time before May 27, 2025.
As of May 27, 2025, we were not eligible for an additional 180 calendar day compliance period, as we did not meet the required Nasdaq
initial listing standards, and, on May 28, 2025, we received a delisting notice from Nasdaq. We have requested an appeal with a Nasdaq
Hearings Panel. There can be no assurance the Staff will grant our request for continued listing.

Corporate Information

We were founded in 1982 and are a Delaware corporation. Our principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648. Our telephone number is (609) 896-9100. Our website is www.imunon.com. The information contained on or that can be accessed through our website is not incorporated by reference into this prospectus, and you should not consider information on our website to be part of this prospectus or in deciding to purchase our Common Stock.

| 3 |

<div align='center'>THE OFFERING</div>

| Shares                                                 
 of Common Stock Offered by the Selling Securityholders |     | Up                                                                                                                                     
 to 22,027,780 shares of Common Stock, consisting of: (i) up to 2,777,779 shares of Common Stock, (ii) up to 4,444,444 shares of Common 
 Stock issuable upon the exercise of the Pre-Funded Warrants, (iii) up to 14,444,446 shares of Common Stock issuable upon the exercise  
 of the Common Warrants, and (iv) 361,111 shares of Common Stock issuable upon the exercise of the Placement Agent Warrants.            |
| Use                                                    
 of Proceeds                                            |     | We                                                                                                                                     
 will not receive any proceeds from any sale of the shares being offered for sale by the Selling Securityholders. We will, however,     
 receive the net proceeds of any Warrants exercised for cash.                                                                           |
| Risk                                                   
 Factors                                                |     | Investing                                                                                                                              
 in our securities involves a high degree of risk. See the “Risk Factors” section of this prospectus for a discussion                   
 of factors that you should consider carefully before buying our securities.                                                            |
| Trading                                                
 Symbol                                                 |     | Our                                                                                                                                    
 Common Stock is listed on Nasdaq under the symbol “IMNN.”                                                                              |

| 4 |

<div align='center'>RISK FACTORS